Sponsored by
This is an interesting development in medical research that warrants attention, as it explores the use of ultrasound to open the blood-brain barrier. It is important to note that this is still very early work, and it remains to be seen if this approach will prove to be effective. The clinical trial is currently open for patients with recurrent glioblastoma at Northwestern University in Illinois, with Dr. Roger Stupp serving as the primary investigator. Dr. Stupp played a pivotal role in developing the standard treatments for glioblastoma, including the Stupp Protocol of radiation and temozolomide followed by temozolomide alone. He also later added Optune to the protocol. With such a track record of working on significant medical breakthroughs, I wish the team success and will continue to monitor their progress closely.